Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging
- Date
- Dec 18, 2025
- Company
- MiramarLab, of Doral, Florida
- Product
- Mamisan Pain Relieving Topical Ointment
- Reason
- The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
- Hazard
- Poisoning
- UPC
- 860006498115
- Units
- About 50,330
- Remedy
- Consumers should immediately secure the recalled ointment jars out of the sight and reach of children and contact Plantimex to receive a free replacement lid. Once the product is secured with the replacement lid, consumers can use the product, as directed.
- Source
- CPSC
Stores named in the notice
- Walmart: “…oisoning; Violates Mandatory Standard for Child-Resistant Packaging Walmart and Target stores nationwide and online at Target.com from April 2024…”
- Target: “…olates Mandatory Standard for Child-Resistant Packaging Walmart and Target stores nationwide and online at Target.com from April 2024 through October 2…”
How to identify the product
- This recall involves Mamisan Pain Relieving Topical Ointment jars. The ointment comes in an orange container with a white continuous thread lid and has the Mamisan trademark printed on top of the lid and on the label. The ointment was sold in a 3.52 ounce plastic jar. The wraparound label includes instructions and drug facts. Only jars with UPC code 860006498115 are included in the recall.
- Sold at: Walmart and Target stores nationwide and online at Target.com from April 2024 through October 2025 for about $10. |
- Consumers should immediately secure the recalled ointment jars out of the sight and reach of children and contact Plantimex to receive a free replacement lid. Once the product is secured with the replacement lid, consumers can use the product, as directed.
Facts are taken from the official notice. If anything here differs from it, the official notice is correct.